<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02695394</url>
  </required_header>
  <id_info>
    <org_study_id>EA1/126/15</org_study_id>
    <nct_id>NCT02695394</nct_id>
  </id_info>
  <brief_title>Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NeuroCure Clinical Research Center, Charite, Berlin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective non-interventional neuropsychological one visit study involving
      functional MRI (fMRI) is to ascertain emotional processing in patients with Multiple
      Sclerosis (MS) or Clinically Isolated Syndrome (CIS) compared to healthy control subjects.

      In different experiments, the modulation of cognitive and motor responses by visual emotional
      information and the ability to discriminate visual emotional stimuli will be tested using
      experimental behavioral paradigms. Furthermore, functional connectivity and - using fMRI -
      activations of brain regions known to be involved with emotional processing will be
      evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Emotional modulation of motor response time</measure>
    <time_frame>1 day</time_frame>
    <description>Δ ([Response time following neutral stimuli] - [Response time following emotional stimuli])</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional memory performance</measure>
    <time_frame>1 day</time_frame>
    <description>%-correct recognized emotional and neutral stimuli</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emotional experience</measure>
    <time_frame>1 day</time_frame>
    <description>Subjective valence and arousal ratings of emotional and neutral stimuli</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BOLD-fMRI brain responses during emotional processing</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expanded Disability Status Scale (EDSS)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiple Sclerosis Functional Composite (MSFC)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form Health Survey (SF-36)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Life Scale (SWLS)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Paced Auditory Serial Addition Test (PASAT)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serial Reaction Time (SRT) Task</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symbol Digit Modalities Test (SDMT)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck depression inventory BDI-2</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive and Negative Affect Schedule (PANAS)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Multiple Sclerosis (MS)</condition>
  <condition>Clinically Isolated Syndrome (CIS)</condition>
  <arm_group>
    <arm_group_label>MS / CIS</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected from a academic medical center MS outpatient clinic.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years and ≤ 85 years

          -  Right handed

          -  For patients: Diagnosis of CIS or diagnosis of MS since ≤5 years

        Exclusion Criteria:

          -  Cognitive deficits as determined by a MMSE Score &lt; 25/30

          -  Depression as determined by a HADS-D Score &gt; 7

          -  Anxiety as determined by a HADS-A Score &gt; 7

          -  Physical disabilities interfering with the study procedures or impacting outcome
             measures

          -  Clinically significant diseases within 7 days prior to the study evaluations

          -  Contraindications against cranial MRI without contrast
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Friedemann Paul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité Unversitätsmedizin Berlin, NeuroCure Clinical Research Center NCRC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas D. Hälbig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité Unversitätsmedizin Berlin, NeuroCure Clinical Research Center NCRC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charité Unversitätsmedizin Berlin; NeuroCure Clinical Research Center NCRC</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://onlinelibrary.wiley.com/doi/10.1111/ene.14269</url>
    <description>Related Info</description>
  </link>
  <results_reference>
    <citation>Hälbig TD, Wüstenberg T, Giess RM, Kunte H, Bellmann-Strobl J, Ruprecht K, Paul F. Emotional experience in patients with clinically isolated syndrome and early multiple sclerosis. Eur J Neurol. 2020 Apr 20. doi: 10.1111/ene.14269. [Epub ahead of print]</citation>
    <PMID>32307769</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 11, 2016</study_first_submitted>
  <study_first_submitted_qc>February 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2016</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>PD Dr. Thomas Hälbig</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <study_docs>
    <study_doc>
      <doc_type>Supporting information: Methods and Results</doc_type>
      <doc_url>https://onlinelibrary.wiley.com/doi/10.1111/ene.14269</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

